Abacavir Sulfate - Uses, Dosage, Warnings, and Side Effects

What Is Abacavir Sulfate?

Abacavir sulfate is a special form of abacavir that is more stable as a salt (sulfate salt). It is similar to guanosine, one of the building blocks of DNA. This medicine helps lower the HIV in your body, protect your immune system, and reduce the risk of developing AIDS.

Abacavir sulfate is a type of chemical called an azaheterocyclic sulfate salt. It works the same way as abacavir, which blocks an enzyme called reverse transcriptase (this enzyme helps HIV make more copies of itself). Your doctor will prescribe this medicine for adults, children, and babies, but it is always used together with other HIV medicines. The FDA (Food and Drug Administration) has approved this medicine for HIV treatment.

Abacavir, sometimes called ABC, is a man-made nucleoside (a DNA building block). It is a strong reverse transcriptase inhibitor. After you take it, abacavir sulfate breaks down into abacavir, the active form, inside your body.

How Does Abacavir Sulfate Work?

Abacavir is used to treat HIV and AIDS. It is a nucleoside analog reverse transcriptase inhibitor (NRTI). A nucleoside analog is a substance that looks like a DNA building block, which tricks the virus and stops it from making more copies of itself.

This medicine has a special chemical shape called a cyclopentene ring, with the configuration labeled 1S, 4R. After you take Abacavir sulfate, it changes into abacavir, the active form, in your body.

Abacavir works by stopping the reverse transcriptase enzyme from working. This enzyme is what HIV uses to copy itself. When abacavir becomes part of the virus DNA, it stops the enzyme and slows down the virus. This helps lower the amount of virus in your body and keeps your immune system stronger. Your doctor will usually give abacavir with other HIV medicines as part of your complete treatment plan.

What Are the Uses of Abacavir Sulfate?

Abacavir does not cure HIV, but it helps lower your risk of HIV infection developing into AIDS and related problems, such as serious infections or certain types of cancer. Using this medicine together with safe sexual practices and healthy lifestyle choices can also lower the chance of passing HIV to others.

Dosage

Abacavir sulfate comes as tablets and as a liquid solution.

Warning

Abacavir can cause serious or life-threatening allergic reactions. If you notice any of the following symptoms, contact your doctor right away:

• Group 1: Fever.

• Group 2: Rash.

• Group 3: Nausea, stomach pain, vomiting, or diarrhea.

• Group 4: Feeling unwell, extreme tiredness, or body aches.

• Group 5: Cough, sore throat, or trouble breathing.

Allergic Reaction:

Some people are more likely to have an allergic reaction because of their genes. Your doctor can do a lab test to see if you are at risk. If you are allergic, do not take abacavir again.

Hypersensitivity Reaction:

People with a gene called HLA-B*5701 may have a greater risk of severe allergic reactions to abacavir. Your doctor will check for this before prescribing it.

For Patients

How Abacavir Works in Your Body?

Abacavir sulfate slows down the HIV virus by stopping it from copying itself. This helps protect your immune system and delays serious health problems linked to HIV or AIDS. Keep in mind that it does not stop HIV from spreading to other people.

Effectiveness:

Abacavir can lower the amount of HIV in your blood and slow the disease if you take it correctly. How well it works depends on your immune system and the stage of your infection.

Things to Tell Your Doctor Before Taking Abacavir

• Tell your doctor and pharmacist if you have any allergies to medications or ingredients in abacavir tablets or liquid.

• Give your doctor a full list of all prescription, over-the-counter, and HIV medicines you take. They may need to adjust your dose or watch for side effects.

• Tell your doctor if you have other health conditions, such as depression, diabetes, high blood pressure, high cholesterol, liver disease, or heart disease.

• If you are planning pregnancy, pregnant, or breastfeeding, let your doctor know.

• Ask your doctor about drinking alcohol while on this medicine.

• Tell your doctor if you have infections like pneumonia, herpes, tuberculosis, hepatitis, or fungal infections. Once your immune system starts to recover, it may begin fighting these infections.

Starting Abacavir Sulfate

Before Taking the Medicine:

You should have a talk with your healthcare professional about the risks and benefits of this drug. They will help you decide if this medicine is right for you.

How to Take Abacavir Sulfate:

• You can only get this medicine with a prescription. It comes in tablets or liquid form.

• Take it by mouth, usually once or twice a day, at the same time each day, with or without food. Take it exactly as your doctor tells you. Do not take more or less than prescribed.

Abacavir does not cure HIV but helps you manage it. Even if you feel well, continue taking it. Stopping the medicine without your doctor’s guidance can make the condition harder to manage or cause an allergic reaction if you start it again.

After Starting the Medicine:

• Take it every day at the same time, as your doctor told you.

• Tell your doctor about any allergies.

• Avoid taking it without your doctor’s permission. Doing so can make your treatment more difficult or trigger an allergic reaction.

Watch for Side Effects:

You may experience some side effects. Contact your doctor if you notice:

• Headache, depression, or anxiety.

• Trouble sleeping.

• Blisters, peeling skin, hives, or itching.

• Trouble swallowing or breathing.

• Extreme tiredness, weakness, dizziness, or lightheadedness.

• Fast or irregular heartbeat.

• Muscle or stomach pain, nausea, or vomiting.

• Shortness of breath.

• Flu-like symptoms such as chills, cough, or fever.

• Feeling cold in the hands or feet.

• Light-colored stool, yellowing of skin or eyes.

• Loss of appetite, unusual bleeding, and bruising.

• Dark urine, or pain in the upper right part of your stomach.

Abacavir may also cause other side effects, which you should discuss with your doctor.

For Doctors

Indication:

Abacavir can be used with other antiretroviral agents for the treatment of HIV-1 infection. It is also available in combination with Dolutegravir and Lamivudine for the treatment of HIV-1 in adult and pediatric patients weighing ≥10 kg.

Pharmacology:

Mechanism of Action:

Abacavir is a synthetic nucleoside analog and antiviral agent that belongs to the carbocyclic class. It is converted into its active metabolite, Carbovir triphosphate, by cellular enzymes after entering the body.

Carbovir triphosphate acts as an analog of deoxyguanosine-5'-triphosphate (dGTP) and competes with it to inhibit the activity of HIV-1 reverse transcriptase (RT). It also inhibits viral DNA growth by getting incorporated into viral DNA and terminating its elongation because of the lack of a 3'-OH group, which is essential for forming the 5′ to 3′ phosphodiester linkage.

Pharmacodynamics:

Upon administration, Abacavir is converted into active metabolites that compete with viral DNA for incorporation. The metabolites act by inhibiting the HIV reverse transcriptase enzyme in a competitive manner and function as a chain terminator of DNA synthesis.

The concentration of drug needed to inhibit viral replication by 50 percent (EC50) ranges from 3.7 to 5.8 μM (1 μM = 0.28 mcg/mL) and 0.07 to 1.0 μM against HIV-1 IIIB and HIV-1BaL, respectively, and was found to be 0.26 ± 0.18 μM against eight clinical isolates. Abacavir demonstrates the non-nucleoside reverse transcriptase inhibitor (NNRTI) when used in combination with Nevirapine, the nucleoside reverse transcriptase inhibitor (NRTI) Zidovudine, and the protease inhibitor (PI) Amprenavir.

Additionally, abacavir exhibits additive activity when used in combination with other NRTI,s including Didanosine, Emtricitabine, Lamivudine, Stavudine, Tenofovir, and Zalcitabine.

Absorption:

The drug is rapidly and extensively absorbed when taken orally.

The bioavailability is 83 %. The peak plasma concentration is 3 mcg/mL (300 mg) and 4.26 mcg/mL (600 mg). The area under the curve (AUC) is 6.02 mcg·h/mL (300 mg) and 11.95 mcg·h/mL (600 mg).

Metabolism and Elimination:

Abacavir sulfate is metabolized by alcohol dehydrogenase and glucuronyl transferase. Around 82% of the administered dose is eliminated through urine as ABC metabolites. In individuals with hepatic insufficiency, dosage adjustment is advised.

Warnings and Precautions:

• Regular visits to your doctor are crucial to ensure that the medication is working effectively. Your doctor may order blood tests to check for any adverse effects.

• Do not use this medicine if a person is already taking other medicines that contain Abacavir.

• Severe allergic reactions may occur in some patients, usually within six weeks of starting the medication. These reactions can lead to low blood pressure and even death if left untreated.

• In case of sudden fever, skin rash, diarrhea, nausea, stomach pain, vomiting, unusual tiredness or illness, cough, trouble breathing, or sore throat, contact the doctor immediately.

• A warning card will be given to the patient that describes the symptoms of severe allergic reactions caused by Abacavir and how to manage them.

• Do not stop using the medication unless instructed by the doctor.

• In case of an allergic reaction to Abacavir, never use the medication again. Return any unused medication.

• Two rare but serious reactions to this medication are lactic acidosis and liver toxicity. Contact the doctor if a child experiences stomach discomfort or cramping, dark urine, decreased appetite, diarrhea, general discomfort, light-colored stools, muscle cramping or pain, nausea, weakness, trouble breathing, vomiting, or yellowing of the eyes or skin.

• This medication may cause excess body fat in some patients. Inform the doctor if a child notices changes in body shape.

• This medication may increase the risk of a heart attack, especially if they smoke or have heart disease, high blood pressure, high cholesterol, or high levels of fats in the blood. Contact the doctor immediately in case of chest pain, nausea, or discomfort in the jaw, back, arm, or neck, trouble breathing, sweating, or vomiting.

• This medication can not be used to prevent needles, toothbrushes, or razor blades with others.

• Consult the doctor before taking any medications or supplements.

Dosage Strength and Forms

For Adults

The dosage forms and strengths of this medicine:

Oral solution at 20 mg/mL and tablet at 300 mg. It is indicated for the treatment of HIV infection in combination with other antiretroviral agents. For HIV infection, the usual dose is 300 mg taken by mouth every 12 hours, or 600 mg taken by mouth once daily.

For Children

• To treat HIV infection along with other antiretroviral agents, this medication is available in an oral solution form with a strength of 20 mg/mL and a tablet form with a strength of 300 mg.

• For neonates and infants under three months of age, the safety of this drug has not been established.

• For those over three months of age, the recommended oral solution dosage is 8 mg/kg taken orally every 12 hours or 16 mg/kg/day. The daily dosage must be within 600 mg.

Dosage and Administration:

For treating HIV infection, oral dosage forms such as solutions or tablets are recommended. The dosage varies based on the age, weight, and health condition of the patient.

Adults are usually prescribed 300 milligrams (mg) of the medication twice per day or 600 mg once a day. Children aged three months or older are prescribed a dose based on their body weight, typically 8 milligrams (mg) per kilogram (kg) of body weight twice a day.

The child's doctor may adjust the dose as necessary, but it usually does not exceed 600 mg per day. For children weighing 14 kg or more who are capable of taking tablets, the dosage is usually 300 to 600 mg per day, taken once daily.

Children under three months old should only use the medication under the guidance and dosage instructions of their doctor.

Considerations for Administration:

Dosage adjustments are not needed in patients with renal impairment. However, for patients with mild hepatic impairment (Child-Pugh A), the dose should be reduced to 200 mg taken by mouth every 12 hours, using the oral solution.

Contraindications:

Abacavir is contraindicated in patients who have had a hypersensitivity reaction to Abacavir, which may include symptoms such as fever, skin rash, nausea, vomiting, diarrhea, abdominal pain, malaise, fatigue, myalgia, and respiratory symptoms.

Patients who have a known hypersensitivity to any component of the product should not use abacavir. Additionally, Abacavir should not be used in patients who have the HLA-B*5701 allele, as this has been associated with a higher risk of hypersensitivity reactions to Abacavir.

Drug Interactions:

To avoid potential drug interactions, you should inform the healthcare professional about all medications, including prescription and over-the-counter drugs. Although some medications should not be used together at all, in other cases, it may be necessary to use two different medicines together, and the doctor may need to adjust the dose or take other precautions.

The following interactions have been identified as significant but may not include all possible interactions:

• The doctor may not recommend using this medicine with Cabotegravir, Orlistat, Ribavirin, or Tacrolimus, but in some cases, both drugs may be prescribed together, and the doctor may adjust the dose or frequency of use.

• Using this medicine with Methadone or Tipranavir may increase the risk of certain side effects. However, both drugs may be necessary for treatment, and the doctor may adjust the dose or frequency of use.

Other Interactions:

Some medications should not be taken with specific types of food or at certain times when eating. Alcohol or tobacco use can also cause interactions with certain medications. It is important to talk to the healthcare provider about the use of the medication in relation to food, alcohol, or tobacco.

Other Specifications

Abacavir Sulfate In Pediatrics:

The safety and effectiveness of abacavir in children under three months of age have not been established, as no appropriate studies have been conducted.

Abacavir Sulfate in Geriatric Patients:

Although no geriatric-specific issues have been identified with Abacavir use, elderly patients may have age-related heart, liver, or kidney problems that may require careful monitoring and dosage adjustments.

Breastfeeding and Abacavir Sulfate:

There is a lack of adequate research on the potential risks to infants when using Abacavir during breastfeeding. Before taking this medication while breastfeeding, consider the possible risks and benefits.

Pregnancy and Abacavir Sulfate:

Abacavir sulfate is generally safe to use during pregnancy when the benefits outweigh the risks. However, it is mandatory to discuss any medication use during pregnancy with the healthcare provider.

The U.S. Food and Drug Administration (FDA) categorizes abacavir sulfate as pregnancy category C, which means that studies on animals have shown side effects on the fetus; however, there are no adequate and well-controlled studies in humans. Therefore, the medication should be used during pregnancy only after carefully making sure that the potential benefits are more than the potential risks to the fetus.